Follow the Money

Responding to growing concern that drug companies were concealing unfavorable results of experiments, in 2004 11 of the world’s top medical-research journals announced that they would require disclosure of continuing clinical trials in a public registry.

The editors of the Journal of the American Medical Association (http://jama.ama-assn.org), The New England Journal of Medicine (http://content.nejm.org), The Lancet (http://www.thelancet.com), and eight other journals announced (http://content.nejm.org/cgi/content/full/NEJMe048225) that they would publish results of trials only if the experiments were registered in an online database.

I wonder what happened to this resolution. Is it being adhered to? More on this…

Advertisements
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s